540:(OAE), which is a sound generated by subtle oscillations of the endo- and perilymph caused by contractions of the outer hair cells of the inner ear in response to a loud sound, seems to offer such a possibility. The sound is transmitted to the stapes, and further through the ossicles, to the tympanic membrane from which it can be detected with a sensitive microphone inserted into the ear canal. OAE is used in clinical practice to test for hearing deficits in babies and children who are too young to cooperate. The equipment can be made portable and is relatively easy to use. Two approaches have commonly utilized that increase the unfavorable signal-to-noise ratio and facilitate extraction of the OAE waveform: transient evoked otoacoustic emission (TEOAE) and distortion product otoacoustic emission (DPOAE). In a recent US patent issued to Meyerson and colleagues proposed the use of both the TEOAE and DPOAE for measurement of ICP. TEOAE is used first to determine the optimum OAE response frequency, after which the pair of pure tones is deployed in a DPOAE paradigm such that the cubic distortion product frequency equals the optimum response frequency while the ratio of frequencies f2/f1 is set to 5:4, and of intensities I2/I1 to 6:5. The inventors also proposed formulae that relate ICP to the intensity or phase of the measured OAE signal, and described how the other physiological signals or behaviors that are known to affect ICP such as small oscillations of ICP with each heartbeat, respiration, or posture changes, can be used to confirm the validity of the obtained measurements (e.g. the absence of modulation of the measured OAE phase with respiration may indicate occlusion of the cochlear aqueduct, in which case OAE cannot provide any information about ICP). There is little data up to date about the clinical utility or accuracy of otoacoustic emission as a measure of ICP. A pilot study of Frank and colleagues that evaluated different modalities of OAE in 12 healthy volunteers and 5 patients with implanted ventricular catheters for direct ICP monitoring revealed that increased ICP or conditions known to increase ICP (e.g. posture changes, abdomen compression, coughing) were associated with notable decreases (between -2.1 and -7.9SPL) in intensity of the evoked OAE. All results were however reported only as group averages, and no attempt was made to derive a quantitative one-to-one relation between the OAE intensity and ICP. This method as all other correlation-based approaches cannot be used for absolute ICP value measurement because of the impossibility of individual calibration.
665:(CRV) and blood velocity in the ophthalmic artery, which taken together highly correlate to intracranial pressure. To obtain CRV pressure, 3ED has developed a novel apparatus that simultaneously record images of the CRV and measures intraocular pressure (IOP) while the pressure in the eye is increased. A medical technician aligns the system by easily centering the field of view to patient's pupil eye. The system then contacts the patient's cornea and simultaneously collects images of the cornea and the retinal fundus. The contact force increases the IOP and momentarily compresses the CRV. At the instant of complete CRV compression, the Cerepress⢠records the eye pressure, which is equivalent to CRV pressure. CRV pressure is a known to be a good correlate to ICP. This method requires an individual patient-specific calibration as every other "correlation-based" method.
505:, which emerges from the posterior wall of the tympanic cavity of the middle ear and inserts into the neck of the stapes (stirrup), prevents excess movements of the stapes by pulling it away from the oval window. The action of either muscle, therefore, dampens vibrations of the ossicles and reduces the amplitude of transmitted sounds for up to 20 dB. The muscles normally contract in response to vocalization, jawing and loud external sounds, which is accompanied by a small but measurable displacement of the eardrum from its initial position. Because cerebrospinal fluid and perilymph communicate through the cochlear aqueduct, an increase in intracranial pressure is directly transmitted to the footplate of the stapes, changing its initial position and affecting thereby the direction and magnitude of the displacement of the
519:(denoted as the baseline position). Equalization of ICP to the atmospheric pressure according to the inventor can be achieved non-invasively by tilting the head up, or the measurement can be taken during a neurosurgical operation. Later on, ICP can be measured by exerting an external pressure to the tympanic membrane and applying simultaneously the same pressure onto the oval window and inner ear (e.g. through the Eustachian tube) until the eardrum is moved back to the baseline position, which will happen when the exerted external pressure equals ICP. No data is provided in the patent nor is available from other sources that could support the utility of the concept in clinical practice.
428:
small but measurable skull expansion which creates additional stress within the skull bones and modifies their mechanical properties. The transfer function is derived by applying a wide-band, low frequency (<100 Hz) mechanical excitation at one location on the skull (via a piezo-transducer or an impact hammer) and comparing its spectrum to that of a signal received at another location on the upper half of skull. It is proposed that the measurement to be self-calibrated by obtaining the frequency response spectrum from a point on the base of the skull of the same subject, which is assumed not to be affected by ICP, or alternatively, pre-calibrated on subjects with normal ICP.
510:
peak pressure on an audiogram) is suggestive of high, and outward of normal or low ICP. The direction and magnitude of TMD, however, depend not only on the initial position of stapes but also on numerous other factors that affect the acoustic impedance (integrity of the eardrum, condition of the ossicles, patency of the
Eustachian tube, pressure and eventual presence of fluid or other masses in the middle ear) or the strength of the acoustic reflex (physiological variability of the reflex threshold, functional integrity of the cochlear and facial nerves, degree of eventual sensory hearing loss). In addition, the assumption that the pressure of
566:
ophthalmodynamometry to determine the pressure in the central retinal vein, which is normally slightly higher (1- 2mmHg) than ICP. Intracranial hypertension also induces changes at the cellular or axonal level such as the swelling of the fibers of the optic nerve that form the innermost layer of the retina (so-called nerve fiber layer â NFL). The information provided by the classic ophthalmoscopy is however only qualitative and may be inconclusive during early phases of intracranial hypertension since it usually takes between two and four hours from the onset of ICP elevation for a papilledema to develop.
260:, brain ventricles, and/or intracranial vessels). The common drawback of all these methods is that they measure only relative changes of ICP as referenced to a baseline measurement during which absolute ICP is known, i.e. the ultrasound readouts need to be calibrated on each subject against an invasive measurement. Ultrasound âtime of the flightâ methods for non-invasive ICP monitoring have not been extensively validated and currently, the majority of them do not seem to be accurate enough for a routine clinical use. Their original formulations usually do not specify locations for the
612:. While the ONSD can at any given point along the optic nerve be measured with a precision of <1mm, the reliability of derived ICP levels is plagued by inter-individual variability and the dependence of ONSD magnitude on the point along the nerve at which the measurement was taken. Almost all validation studies so far have recommended that ONSD to be used for identification of patients with intracranial hypertension that requires treatment (ICP>20mmHg, i.e. ONSD>5mmHg) rather than for a measurement of ICP.
217:
eye socket. In place of the stethoscope, a
Doppler ultrasound beam measures the blood flow pulsations in intracranial and extracranial segments of the ophthalmic artery. The non-invasive ICP meter based on this method gradually increases the pressure over the eyeball and intraorbital tissues so that the blood flow pulsation parameters in two sections of the OA are equal. At this pressure balance point, the applied external pressure (Pe) equals the intracranial pressure (ICP).
451:(NASDAQ: LUNA) developed EN-TACT system, an ultrasound device for monitoring compartment syndrome. The technology was claimed to have applications for raised intracranial pressure. Based on research from the NASA Ames research center, the company used ultrasound to measure skull diameter changes caused by ICP changes. However, skull changes are tiny and only indirectly related to ICP, raising questions about the accuracy and calibration.
213:(OA), a unique vessel with intracranial and extracranial segments, is used as a pressure sensor and as a natural pair of scales for absolute ICP value in mmHg or mmH2O measurement. Blood flow in the intracranial OA segment is affected by intracranial pressure, while flow in the extracranial (intraorbital) OA segment is influenced by the externally applied pressure (Pe) to the eyeball and orbital tissues.
636:
clinically negligible differences (2-3mmHg) between VOP and the invasively measured ICP. Ophthalmodynamometry requires dilated pupils, a skilled physician or medic, and collaboration of the patient, which all hampers its applicability in the field. It cannot be applied in cases of ocular trauma or conditions that selectively affect the optic nerve and gives erroneously high readings in the presence of a
627:. The pressure is gradually increased until the central retinal vein begins to pulsate, which happens at the point when the applied external pressure nears the VOP and is approximately equal to ICP. The original method was described in 1925 by Baurmann and belongs to the public domain, but several modifications have been recently patented that combine the classic ophthalmodynamometry with reflectance
229:
absolute value (mmHg) measurement method which does not need an individual patient-specific calibration. High accuracy, precision, sensitivity and specificity of the proposed method are fully acceptable for clinical practice and for very wide applications in neurology, transplantology, intensive care, sports medicine, aerospace medicine, and combat casualty care.
264:'s placement and do not address how the intentional or accidental use of different locations and/or angles of the transducers will affect the reliability of ICP estimates. It has also remained unexplored how the measurements are affected by the presence of intracranial pathological masses on the path of the ultrasound wave, or by brain masses shifts.
33:
130:, stroke, and death. However, aside from a few Level I trauma centers, ICP monitoring is rarely a part of the clinical management of patients with these conditions. The infrequency of ICP can be attributed to the invasive nature of the standard monitoring methods (which require insertion of an ICP sensor into the
509:
in response to a sound. The displacement can be measured with common tympanometers used for impedance audiometry that are portable and relatively inexpensive and easy to use (particularly the modern, computerized tympanometers with fully automated measurement procedure). Inward displacement (negative
440:
of the cranium are calculated from the phase difference between a sinusoidal excitatory signal, delivered with a piezo-transducer, and the response that is received at a distance with another piezotransducer. In the second step, changes in ICP are calculated as a product of the changes in the cranium
403:
ICP can be estimated from the TCD measurements because it impedes the blood flow and consequently decreases the velocity of blood flow. Besides the mean velocity, pulsatility index (which is the difference between peak systolic and end diastolic velocity, divided by mean flow velocity), a fraction of
375:
and detecting a frequency shift between the incident and reflected wave which directly correlates with the speed of the blood (the so-called
Doppler effect). The measurement is taken over the regions of the skull with thinner walls (temporal region, back of the head, or through the eye), as the bones
310:
or respiration, where the pulsations are measured along the propagation axis of an ultrasound wave. The method so far has not been independently validated, and the author provides no exact data from which one could estimate the accuracy of the method. However, the discussion in the body of the patent
280:
and calculates the corresponding distance(s) using known ultrasound propagation velocities in different tissues (e.g. bone, brain, or fluid). Unfortunately, a reproducible quantitative relationship between the diameter of the cranium and ICP could not be established because ICP-induced changes in the
435:
excitation at the resonant frequency is delivered through a piezo-transducer, and ICP is calculated directly from the phase difference between the excitatory signal and response detected with a second transducer. Yost and
Cantrell divided the process into two steps. In the first step, changes in the
427:
Methods from this group attempt to derive ICP from mechanical properties of the skull bones rather than of the intracranial content. The underlying assumption is similar to that of the ultrasound time of the flight techniques: that the skull is not completely rigid so that changes in ICP result in a
314:
Method and device for non-invasive (NI) ICP measurement according to inventions of David
Michaeli MD, PhD, based to the TRA (tissue resonance analysis) have 2 options: (1) The qualitative method makes an evaluation of mild (10-20mm.Hg), moderate (20-40) and severe (above 40mmHg) ICP elevation. These
201:
to listen for the return of blood flow. At the pressure balance point, where the pressure in the cuff equals systolic artery pressure, a âwhooshingâ noise can be heard as blood flows through the artery again. Pressure balance based a non-invasive blood pressure meter does not need a patient-specific
414:
used transcranial
Doppler ultrasound to measure ICP indirectly by assessing the elasticity of the biological material in a defined part of the brain. However, the elasticity in the brain is highly dependent on many other variable individual factors apart from ICP, including arterial blood pressure,
535:
are dominantly determined by the structures and functional properties of the middle ear, and only marginally influenced by changes in ICP. A measurable acoustic phenomenon that originates in the inner ear would, at least in theory, allow for more precise assessment of the pressure of the peri- and
228:
Ragauskas A. et al. have already published the statistically significant results of a prospective clinical study on assessment of the accuracy and precision of proposed non-invasive absolute ICP value measurement method. The study shows that proposed method is the only quantitative noninvasive ICP
224:
The mean value of OA blood flow, its systolic and diastolic values, pulsatility and other indexes are almost the same in both OA segments in the point of balance when ICP equals Pe. As a result of that, all individual influential factors (ABP, cerebrovascular auto-regulation impairment, individual
216:
As with a sphygmomanometer, a special pressure cuff is used - in this case, to compress the tissues surrounding the eyeball and also intraorbital tissues surrounding the extracranial segment of OA. External pressure changes the characteristics of blood flowing from inside the skull cavity into the
1219:
Robba, Chiara; Santori, Gregorio; Czosnyka, Marek; Corradi, Francesco; Bragazzi, Nicola; Padayachy, Llewellyn; Taccone, Fabio Silvio; Citerio, Giuseppe (17 July 2018). "Optic nerve sheath diameter measured sonographically as non-invasive estimator of intracranial pressure: a systematic review and
635:
or ultrasound measurement of blood flow in the central retinal artery, or automate the method by adding a camera and an image processing software capable of recognizing venous pulsations from a sequence of images of the eye fundus. Evaluation in patients confirmed a strong linear relationship and
488:
to vibrate, activating ultimately the acoustic sensor cells, the inner hair cells of the organ of Corti. The transfer function of this complex mechanical system under physiological conditions is modulated by the action of two small muscles of the middle ear, the tensor tympani, and stapedius. The
297:
that is estimated from interference echoes of an ultrasonic wave. The utility of the method was successfully confirmed on four healthy subjects and four patients with intracranial hypertension, but larger validation studies have never been conducted as the method failed to attract enough interest
220:
This measurement method eliminates the main limiting problem of all other non-successful approaches to non-invasive ICP measurement, primarily the individual patient calibration problem. Direct comparison of arterial blood pressure (ABP) and externally applied pressure is the basic arterial blood
514:
is equal to ICP does not hold if the patency of the cochlear aqueduct is compromised, which is often the case in elderly subjects. Accuracy of TMD estimates of ICP was found to be at the order of Âą15mmHg, which is not sufficient for a reliable quantitative assessment of ICP in clinical practice.
565:
and have therefore been used by clinicians for more than a century as signs of increased ICP. Quantitative assessment of ICP can be made noninvasively in two different ways: by measuring changes in diameter of the optic nerve sheath with an appropriate technique (ultrasound or MRI), or by using
591:
alignment of the optic nerve and propagation axis of the ultrasound wave, but the precision was significantly improved with the use of B-scan (or planar) ultrasound which provided longitudinal cross-section images of the optic nerve and its sheath. Since then, the method has been successfully
518:
An interesting method that involves direct manipulations on the tympanic membrane rather than relying on the acoustic reflex was proposed as one of the embodiments of a US patent by
Ragauskas. First, a measurement of the position of the tympanic membrane needs to be obtained while ICP is zero
342:
Ultrasound ICP monitors based on the latter approach, which were developed at
Vittamed Technologijos (Kaunas, Lithuania), have shown an impressive agreement with invasively measured ICP, with an average difference of only 2â3 mmHg in a small clinical population. However Vittamed Technologijos
556:
whose pressure is equal to intracranial pressure. Intracranial hypertension will thus manifest in an increased diameter of the optic nerve sheath and will impede the blood flow through the central retinal vein that courses within the sheath, along and in part inside of the optical nerve. The
586:
The use of optic nerve sheath diameter (ONSD) for the assessment of ICP dates back to 1987 when
Cennamo and colleagues demonstrated a linear relationship between ICP and the sheath diameter measured with a trans-orbital ultrasound probe in an A-scan mode (principally equivalent to the
459:
Tympanic membrane displacement (TMD) technique, proposed nearly twenty years ago by
Marchbanks exploits the effect of intracranial pressure on the acoustic reflex, i.e. a reflex contraction of the stapedius and tensor tympani muscles in response to a sound. Normally, vibrations of the
444:
None of the aforementioned methods has been properly validated in relevant clinical populations, and their accuracy is unknown. One may assume however that it would be comparable to the ultrasound time-of-the-flight methods, and thus insufficient for a routine clinical use.
577:
and infers ICP from it laid claims of being able to detect the IH-induced thickening of the retina shortly after the onset of IH, but there has been no data that would support the claims or clarify the relationship between the NFL thickness and levels of ICP.
311:
document suggests that the method is able to distinguish among three ranges of ICP (<20, 20â40 and >40mmHg) but cannot provide an exact value of ICP within the range because of the impossibility of the calibration to the individual patient.
225:
pathophysiological state of patience, individual diameter, and anatomy of OA, hydrodynamic resistance of eyeball vessels, etc.) do not influence the balance of ICP equaling Pe and, as a consequence, such natural âscalesâ do not need calibration.
646:
developed technology based on Braxton's patent. They won Purdue University's business plan competition in 2006 and were using the funds to develop iScan, its initial prototype. The approach worked on measuring ICP non-invasively by
188:
An innovative method using a two-depth transorbital doppler (TDTD) of intracranial pressure quantitative absolute (ICP) value measurement relies on the same fundamental principle that is used to measure blood pressure with a
1142:
Frank, A. M.; Alexiou, C.; Hulin, P.; Janssen, T.; Arnold, W.; Trappe, A. E. (2000). "Non-invasive measurement of intracranial pressure changes by otoacoustic emissions (OAEs)--a report of preliminary data".
221:
pressure measurement principle, which eliminates the need for individual calibration. The same calibration-free fundamental principle is used in the TDTD non-invasive ICP absolute value measurement method.
548:
Eye provides another possible window into the pressure changes in the intracranial compartment thanks to the fact that the space between the optic nerve and its sheath is a continuation of the
197:
to a point where blood can no longer flow. Externally applied pressure is equal to systolic blood pressure in this case. The examiner slowly releases the air from the cuff and uses a
1073:
Shimbles S, Dodd C, Banister K, Mendelow AD, Chambers IR (December 2005). "Clinical comparison of tympanic membrane displacement with invasive intracranial pressure measurements".
248:
The majority of patented methods for noninvasive monitoring of ICP are based on an assumption that changes in ICP affect the physical dimensions and/or acoustic properties of the
158:
Many approaches to non-invasive ICP estimation are based on the idea that something in the human head's anatomical structure or in the intracranial and extracranial physiology
1327:
175:
The only accurate, precise, and patient-specific, calibration-free, non-invasive, absolute ICP value measurement method relies not on the correlation, but on direct ICP and
138:). Additional risks presented to patients can include high costs associated with an ICP sensor's implantation procedure, and the limited access to trained personnel, e.g. a
1186:
Cennamo, G.; Gangemi, M.; Stella, L. (1987). "The correlation between endocranial pressure and optic nerve diameter: an ultrasonographic study". In Ossoinig, K. C. (ed.).
376:
strongly attenuate the transmission of the ultrasound at these frequencies. TCD is primarily a technique for diagnosing various intracranial vascular disorders such as
170:) and precision (expressed by the standard deviation of random error). Measuring absolute ICP value is limited by the need for individual patient-specific calibration.
431:
Other methods from this group vary this basic approach of Mick in different ways. In Sinha's method resonant frequency of the skull bones is determined first, then a
835:
441:
circumference and the elasticity constant of the skull that has been determined earlier by causing known changes in ICP while measuring the cranium circumference.
777:
Ragauskas A, Matijosaitis V, Zakelis R, et al. (May 2012). "Clinical assessment of noninvasive intracranial pressure absolute value measurement method".
408:
and slopes of the TCD waveforms have been correlated with ICP. The estimates are however insufficiently accurate with the margin of error of Âą10 - 15 mmHg.
587:
time-of-the-flight measurements of the cranium diameter). The original measurement method was technically difficult and unreliable because of the nearly
272:
Dimensions of the cranium or its structures are determined with the ultrasound âtime-of-the-flightâ technique that measures the transit time of an
1320:
1203:
651:. However this is dependent on other factors apart from ICP, so it will be difficult to generate accuracy sufficient for clinical practice.
623:
Performed by applying external pressure on the sclera, for example with a spring plunger, while observing the retinal vessels through an
615:
ONSD measurement by ultrasound is not as precise as invasive ICP measurement but may be useful if invasive measurement is not available.
961:
Ragauskas A, Daubaris G, Ragaisis V, Petkus V (October 2003). "Implementation of non-invasive brain physiological monitoring concepts".
1313:
306:
Michaeli proposed that ICP should be inferred from the magnitude and shape of pulsations of the third ventricle synchronous with the
1490:
1485:
72:
1272:
18. M. Ăber die Entstehung und Klinische Bedeutung des Netzhautvenenpulses. Ber Zusammenkunft Dtsch Ophthalmol Ges 1925; 45: 53-59.
319:
OF ICP WAVES with special ICP formulation in mm.Hg., Developed new device and method for calibration of ICP for each patient; see
193:. A sphygmomanometer works using a pressure balance principle - an air-filled pressure cuff wrapped around the arm compresses the
1368:
684:
1439:
343:
time-of-flight technologies were developed further for other applications of neuro-monitoring technologies (including cerebral
209:
to translate the pressure balance principle of blood pressure measurement with a sphygmomanometer to the measurement of ICP.
1586:
561:(venous engorgement, and papilledema, i.e. swelling and elevation of the optic nerve disc) that can be observed with an
501:(hammer); its contraction pulls the malleus medially, away from the tympanic membrane, which tenses the membrane. The
17:
50:
43:
331:
More recently, multivariate methods have been proposed that derive ICP by combining the transit times with measured
849:
Petkus V, Ragauskas A, Jurkonis R (May 2002). "Investigation of intracranial media ultrasonic monitoring model".
699:
904:"Tissue resonance analysis; a novel method for noninvasive monitoring of intracranial pressure. Technical note"
679:
119:
339:
and ultrasound velocity, or with a dispersion of the ultrasound wave on its way through the brain parenchyma.
1444:
609:
601:
348:
206:
315:
method is using NI, long-term recording of ICP waves patterns, Like Lundsbergs ICP waves. (2) Quantitative
176:
1576:
1528:
1480:
1424:
1399:
704:
393:
111:
1363:
674:
261:
103:
489:
tensor tympani arises from the cartilaginous portion of the auditory tube and the osseous canal of the
1581:
1533:
1508:
1082:
537:
1523:
1429:
553:
173:
Absolute ICP values in mmHg or other units are needed to determine the correct patient treatment.
1470:
1255:
1106:
802:
549:
528:
405:
336:
131:
709:
1513:
1460:
1247:
1199:
1168:
1160:
1098:
1019:
978:
925:
883:
Kageyama, N., Kuchiwaki, H., Ito, J., Sakuma, N., Ogura, Y., Minimiyama, F.: US4971061 (1990).
866:
829:
794:
759:
730:
574:
461:
389:
210:
1475:
1434:
1416:
1237:
1229:
1191:
1152:
1090:
1009:
970:
915:
858:
786:
481:
190:
167:
166:
approaches can reflect factors associated with ICP only with limited accuracy (expressed by
657:
is developing the Cerepressâ˘, a non-invasive, hand-held intracranial pressure monitor that
1519:
532:
194:
1086:
1551:
1337:
1014:
998:"Adaptive noninvasive assessment of intracranial pressure and cerebral auto-regulation"
997:
624:
562:
344:
107:
54:
974:
862:
1570:
1094:
605:
597:
490:
437:
307:
249:
122:. It can cause complications such as vision impairment due to intracranial pressure (
1259:
1110:
806:
619:
Ophthalmodynamometry or the measurement of the retinal venous outflow pressure (VOP)
1305:
662:
364:
298:
among clinicians. This method also needs a calibration to the individual patients.
257:
139:
1195:
790:
592:
validated in several relatively large studies that included patients with severe
1356:
735:
637:
593:
472:. Vibrations of the footplate of stapes transmit through the oval window to the
282:
281:
cranium diameter are very small compared to the inter-individual variability of
198:
49:
The references used may be made clearer with a different or consistent style of
920:
903:
750:
Allocca JA (February 1982). "Noninvasive monitoring of intracranial pressure".
1233:
694:
570:
558:
432:
372:
320:
294:
273:
253:
135:
1164:
419:. Therefore, this approach would require calibration and expert positioning.
1465:
511:
502:
494:
477:
473:
464:(eardrum) elicited by acoustic stimuli are transmitted through the chain of
385:
332:
1251:
1172:
1102:
1023:
982:
929:
870:
798:
763:
493:
and, having sharply bent over the extremity of the septum, attaches to the
1156:
689:
628:
468:(malleus, incus, and stapes) in the middle ear to the oval window of the
465:
381:
360:
127:
1242:
1351:
1190:. Documenta Ophthalmologica Proceedings. Vol. 48. pp. 603â6.
588:
506:
498:
469:
277:
126:), permanent neurological problems, reversible neurological problems,
1394:
1378:
632:
397:
388:, and can be used to identify patients who are at risk of developing
377:
293:
The method claims that ICP can be inferred from the thickness of the
276:
wave and its (potentially multiple) echoes on their path through the
115:
821:
110:
that accompanies a variety of pathological conditions, most notably
1373:
527:
TMD fails to provide accurate estimates of ICP mostly because the
485:
416:
123:
1309:
1132:
16. Meyerson, S.C., Avan, P.A., Buki, B.: US20036589189 (2003).
415:
state of cerebral blood flow auto-regulation, and the level of
237:
661:. The Cerepress⢠measures blood pressure in the eye's central
368:
26:
996:
Schmidt B, Czosnyka M, Raabe A, et al. (January 2003).
236:
along with consortium partners in EU FP7 projects BrainSafe
640:, which may persist long after ICP has returned to normal.
557:
impediment of venous return causes visible changes in the
88:
Non-invasive intracranial pressure measurement methods
18:
Non-invasive intracranial pressure measurement methods
1054:
12. Yost, W.T., Cantrell, J.H.: US20046746410 (2004).
659:
gathers information from the patient's un-dilated eye
1544:
1501:
1453:
1415:
1408:
1387:
1344:
951:
7. Ragauskas A, A., Daubaris, G.: US5388583 (1995).
92:
87:
569:A patented method that utilizes optical coherence
822:"Noninvasive Monitoring of Intracranial Pressure"
729:Dugdale, David C.; Sheth, Kevin (June 18, 2011).
232:This method was further developed by the Company
144:non-invasive measurement of intracranial pressure
820:Popovic, Djordje; Khoo1, Michael; Lee, Stefan.
106:(ICP) is one of the major causes of secondary
1321:
363:of blood flow through the major intracranial
8:
1281:19. Denninghoff, K.R.: US20026390989 (2002).
834:: CS1 maint: numeric names: authors list (
649:assessing changes in the retinal blood flow
1412:
1328:
1314:
1306:
1290:20. Querfurth, H.W.: US20067122007 (2006).
1241:
1013:
919:
73:Learn how and when to remove this message
1299:21. Braxton, E.E.: US20060206037 (2006).
1123:15. Ragauskas, A.: US20067147605 (2006).
244:Ultrasound time of the flight techniques
1063:13. Marchbanks, R.J.: US4841986 (1989).
721:
148:non-invasive methods for estimating ICP
1045:11. Sinha, D.N.: US20006117089 (2000).
902:Michaeli D, Rappaport ZH (June 2002).
827:
536:endo-lymph, and consequently, of ICP.
84:
644:Neurolife Non-invasive Solutions Inc.
184:Two depth transorbital doppler (TDTD)
7:
355:Transcranial Doppler ultrasonography
942:6. Bridger et al. US5919144 (1999).
367:by emitting a high frequency (>2
1015:10.1161/01.STR.0000047849.01376.AE
552:, and is consequently filled with
25:
731:"Increased intracranial pressure"
1369:Lateralization of brain function
892:Michaeli, D.: WO00068647 (2000).
685:Intracranial pressure monitoring
573:to measure the thickness of the
150:have, as a result, been sought.
31:
1440:Somatosensory evoked potentials
1145:Zentralblatt fĂźr Neurochirurgie
1036:10. Mick, E.: US5074310 (1991).
285:sizes, shapes and thicknesses.
455:Tympanic membrane displacement
1:
975:10.1016/S1350-4533(03)00082-1
863:10.1016/S0041-624X(02)00216-0
449:Luna Innovations Incorporated
240:, Brainsafe II, and TBIcare.
1196:10.1007/978-94-009-3315-6_99
791:10.1212/WNL.0b013e3182574f50
252:or intracranial structures (
154:Correlation-based approaches
655:Third Eye Diagnostics, Inc.
582:Optic nerve sheath diameter
531:and its changes due to the
476:, which in turn causes the
1603:
1095:10.1088/0967-3334/26/6/017
921:10.3171/jns.2002.96.6.1132
371:) wave from an ultrasound
1435:Auditory evoked potential
1234:10.1007/s00134-018-5305-7
1075:Physiological Measurement
700:Space adaptation syndrome
680:Intracranial hypotension
120:intracranial hemorrhages
1445:Visual evoked potential
1222:Intensive Care Medicine
610:acute mountain sickness
602:intracranial hemorrhage
1529:Long-term potentiation
1481:Postsynaptic potential
1425:Bereitschaftspotential
705:Traumatic brain injury
394:traumatic brain injury
112:traumatic brain injury
1364:Intracranial pressure
1188:Ophthalmic Echography
675:Intracranial pressure
359:The TCD measures the
289:Thickness of the dura
211:The ophthalmic artery
205:The TDTD method uses
179:comparison principle.
177:extracranial pressure
104:intracranial pressure
1587:Neurology procedures
1534:Long-term depression
1509:Axoplasmic transport
1157:10.1055/s-2000-15597
608:, and climbers with
538:Otoacoustic emission
523:Otoacoustic emission
1524:Synaptic plasticity
1516:/Nerve regeneration
1087:2005PhyM...26.1085S
554:cerebrospinal fluid
544:Ocular measurements
484:, and the organ of
392:in early phases of
164:"Correlation-based"
1471:Membrane potential
1336:Physiology of the
550:subarachnoid space
529:acoustic impedance
412:Physiosonics, Inc.
337:resonant frequency
321:patent description
302:Cerebral ventricle
207:Doppler ultrasound
136:parenchymal tissue
1564:
1563:
1560:
1559:
1514:Neuroregeneration
1461:Neurotransmission
1205:978-94-010-7988-4
575:nerve fiber layer
462:tympanic membrane
390:cerebral ischemia
100:
99:
83:
82:
75:
16:(Redirected from
1594:
1476:Action potential
1454:Other short term
1417:Evoked potential
1413:
1330:
1323:
1316:
1307:
1300:
1297:
1291:
1288:
1282:
1279:
1273:
1270:
1264:
1263:
1245:
1228:(8): 1284â1294.
1220:meta-analysis".
1216:
1210:
1209:
1183:
1177:
1176:
1139:
1133:
1130:
1124:
1121:
1115:
1114:
1070:
1064:
1061:
1055:
1052:
1046:
1043:
1037:
1034:
1028:
1027:
1017:
993:
987:
986:
958:
952:
949:
943:
940:
934:
933:
923:
899:
893:
890:
884:
881:
875:
874:
846:
840:
839:
833:
825:
817:
811:
810:
774:
768:
767:
747:
741:
740:
726:
482:basilar membrane
327:Brain parenchyma
268:Cranium diameter
191:sphygmomanometer
168:systematic error
85:
78:
71:
67:
64:
58:
35:
34:
27:
21:
1602:
1601:
1597:
1596:
1595:
1593:
1592:
1591:
1567:
1566:
1565:
1556:
1540:
1520:Neuroplasticity
1497:
1449:
1404:
1383:
1340:
1334:
1304:
1303:
1298:
1294:
1289:
1285:
1280:
1276:
1271:
1267:
1218:
1217:
1213:
1206:
1185:
1184:
1180:
1141:
1140:
1136:
1131:
1127:
1122:
1118:
1072:
1071:
1067:
1062:
1058:
1053:
1049:
1044:
1040:
1035:
1031:
995:
994:
990:
960:
959:
955:
950:
946:
941:
937:
901:
900:
896:
891:
887:
882:
878:
857:(1â8): 829â33.
848:
847:
843:
826:
819:
818:
814:
785:(21): 1684â91.
776:
775:
771:
749:
748:
744:
728:
727:
723:
718:
710:Cushing's triad
671:
621:
584:
546:
533:acoustic reflex
525:
457:
425:
357:
329:
304:
291:
270:
246:
195:brachial artery
186:
156:
142:. Alternative,
132:brain ventricle
79:
68:
62:
59:
48:
42:has an unclear
36:
32:
23:
22:
15:
12:
11:
5:
1600:
1598:
1590:
1589:
1584:
1579:
1569:
1568:
1562:
1561:
1558:
1557:
1555:
1554:
1552:Myelinogenesis
1548:
1546:
1542:
1541:
1539:
1538:
1537:
1536:
1531:
1517:
1511:
1505:
1503:
1499:
1498:
1496:
1495:
1494:
1493:
1488:
1478:
1473:
1468:
1463:
1457:
1455:
1451:
1450:
1448:
1447:
1442:
1437:
1432:
1427:
1421:
1419:
1410:
1406:
1405:
1403:
1402:
1397:
1391:
1389:
1385:
1384:
1382:
1381:
1376:
1371:
1366:
1361:
1360:
1359:
1348:
1346:
1342:
1341:
1338:nervous system
1335:
1333:
1332:
1325:
1318:
1310:
1302:
1301:
1292:
1283:
1274:
1265:
1211:
1204:
1178:
1151:(4): 177â180.
1134:
1125:
1116:
1081:(6): 1085â92.
1065:
1056:
1047:
1038:
1029:
988:
953:
944:
935:
894:
885:
876:
841:
812:
769:
742:
720:
719:
717:
714:
713:
712:
707:
702:
697:
692:
687:
682:
677:
670:
667:
625:ophthalmoscope
620:
617:
583:
580:
563:ophthalmoscope
545:
542:
524:
521:
456:
453:
424:
421:
356:
353:
345:Autoregulation
328:
325:
303:
300:
290:
287:
269:
266:
245:
242:
185:
182:
155:
152:
108:brain ischemia
98:
97:
94:
90:
89:
81:
80:
44:citation style
39:
37:
30:
24:
14:
13:
10:
9:
6:
4:
3:
2:
1599:
1588:
1585:
1583:
1580:
1578:
1577:Medical signs
1575:
1574:
1572:
1553:
1550:
1549:
1547:
1543:
1535:
1532:
1530:
1527:
1526:
1525:
1521:
1518:
1515:
1512:
1510:
1507:
1506:
1504:
1500:
1492:
1489:
1487:
1484:
1483:
1482:
1479:
1477:
1474:
1472:
1469:
1467:
1464:
1462:
1459:
1458:
1456:
1452:
1446:
1443:
1441:
1438:
1436:
1433:
1431:
1428:
1426:
1423:
1422:
1420:
1418:
1414:
1411:
1407:
1401:
1398:
1396:
1393:
1392:
1390:
1388:Primarily PNS
1386:
1380:
1377:
1375:
1372:
1370:
1367:
1365:
1362:
1358:
1355:
1354:
1353:
1350:
1349:
1347:
1345:Primarily CNS
1343:
1339:
1331:
1326:
1324:
1319:
1317:
1312:
1311:
1308:
1296:
1293:
1287:
1284:
1278:
1275:
1269:
1266:
1261:
1257:
1253:
1249:
1244:
1239:
1235:
1231:
1227:
1223:
1215:
1212:
1207:
1201:
1197:
1193:
1189:
1182:
1179:
1174:
1170:
1166:
1162:
1158:
1154:
1150:
1146:
1138:
1135:
1129:
1126:
1120:
1117:
1112:
1108:
1104:
1100:
1096:
1092:
1088:
1084:
1080:
1076:
1069:
1066:
1060:
1057:
1051:
1048:
1042:
1039:
1033:
1030:
1025:
1021:
1016:
1011:
1007:
1003:
999:
992:
989:
984:
980:
976:
972:
969:(8): 667â78.
968:
964:
957:
954:
948:
945:
939:
936:
931:
927:
922:
917:
914:(6): 1132â7.
913:
909:
905:
898:
895:
889:
886:
880:
877:
872:
868:
864:
860:
856:
852:
845:
842:
837:
831:
823:
816:
813:
808:
804:
800:
796:
792:
788:
784:
780:
773:
770:
765:
761:
757:
753:
746:
743:
738:
737:
732:
725:
722:
715:
711:
708:
706:
703:
701:
698:
696:
693:
691:
688:
686:
683:
681:
678:
676:
673:
672:
668:
666:
664:
660:
656:
652:
650:
645:
641:
639:
634:
630:
626:
618:
616:
613:
611:
607:
606:liver failure
603:
599:
598:hydrocephalus
595:
590:
581:
579:
576:
572:
567:
564:
560:
555:
551:
543:
541:
539:
534:
530:
522:
520:
516:
513:
508:
504:
500:
496:
492:
487:
483:
479:
475:
471:
467:
463:
454:
452:
450:
446:
442:
439:
438:circumference
434:
429:
422:
420:
418:
413:
409:
407:
404:the cycle in
401:
399:
395:
391:
387:
383:
379:
374:
370:
366:
362:
354:
352:
350:
347:and Cerebral
346:
340:
338:
334:
326:
324:
322:
318:
312:
309:
308:cardiac cycle
301:
299:
296:
288:
286:
284:
279:
275:
267:
265:
263:
259:
255:
251:
250:cranial vault
243:
241:
239:
235:
230:
226:
222:
218:
214:
212:
208:
203:
202:calibration.
200:
196:
192:
183:
181:
180:
178:
171:
169:
165:
161:
153:
151:
149:
145:
141:
137:
133:
129:
125:
121:
117:
113:
109:
105:
95:
91:
86:
77:
74:
66:
56:
52:
46:
45:
40:This article
38:
29:
28:
19:
1295:
1286:
1277:
1268:
1243:11567/918741
1225:
1221:
1214:
1187:
1181:
1148:
1144:
1137:
1128:
1119:
1078:
1074:
1068:
1059:
1050:
1041:
1032:
1005:
1001:
991:
966:
963:Med Eng Phys
962:
956:
947:
938:
911:
908:J. Neurosurg
907:
897:
888:
879:
854:
850:
844:
815:
782:
778:
772:
755:
752:Med Electron
751:
745:
734:
724:
663:retinal vein
658:
654:
653:
648:
643:
642:
622:
614:
585:
568:
547:
526:
517:
458:
448:
447:
443:
430:
426:
411:
410:
402:
358:
341:
330:
316:
313:
305:
292:
271:
258:brain tissue
247:
234:Vittamed Ltd
233:
231:
227:
223:
219:
215:
204:
187:
174:
172:
163:
159:
157:
147:
143:
140:neurosurgeon
101:
69:
60:
41:
1582:Neurotrauma
1357:Wakefulness
1008:(1): 84â9.
851:Ultrasonics
758:(1): 81â5.
736:MedlinePlus
638:papilledema
604:or stroke,
594:head trauma
423:Skull bones
335:impedance,
317:measurement
199:stethoscope
96:measure ICP
1571:Categories
1491:Inhibitory
1486:Excitatory
716:References
695:Meningitis
571:tomography
559:eye fundus
433:sinusoidal
349:Compliance
295:dura mater
274:ultrasound
262:transducer
162:with ICP.
160:correlates
102:Increased
55:footnoting
1502:Long term
1466:Chronaxie
1400:Sensation
1165:0044-4251
779:Neurology
512:perilymph
503:stapedius
495:manubrium
478:endolymph
474:perilymph
386:vasospasm
238:Brainsafe
63:July 2013
1260:49869420
1252:30019201
1173:11392287
1111:17430607
1103:16311455
1024:12511755
983:12900182
930:12066918
871:12160053
830:cite web
807:45033245
799:22573638
764:10254587
690:Headache
669:See also
629:oximetry
491:sphenoid
466:ossicles
382:stenosis
361:velocity
333:acoustic
128:seizures
51:citation
1352:Arousal
1083:Bibcode
631:of the
589:coaxial
507:eardrum
499:malleus
497:of the
470:cochlea
406:systole
365:vessels
278:cranium
116:strokes
114:(TBI),
93:Purpose
1395:Reflex
1379:Memory
1258:
1250:
1202:
1171:
1163:
1109:
1101:
1022:
1002:Stroke
981:
928:
869:
805:
797:
762:
633:retina
480:, the
398:stroke
378:emboli
118:, and
1545:Other
1374:Sleep
1256:S2CID
1107:S2CID
803:S2CID
486:Corti
417:edema
384:, or
373:probe
283:skull
1430:P300
1409:Both
1248:PMID
1200:ISBN
1169:PMID
1161:ISSN
1099:PMID
1020:PMID
979:PMID
926:PMID
867:PMID
836:link
795:PMID
760:PMID
254:dura
124:VIIP
53:and
1238:hdl
1230:doi
1192:doi
1153:doi
1091:doi
1010:doi
971:doi
916:doi
859:doi
787:doi
396:or
369:MHz
351:).
134:or
1573::
1254:.
1246:.
1236:.
1226:44
1224:.
1198:.
1167:.
1159:.
1149:61
1147:.
1105:.
1097:.
1089:.
1079:26
1077:.
1018:.
1006:34
1004:.
1000:.
977:.
967:25
965:.
924:.
912:96
910:.
906:.
865:.
855:40
853:.
832:}}
828:{{
801:.
793:.
783:78
781:.
756:13
754:.
733:.
600:,
596:,
400:.
380:,
323:.
256:,
146:,
1522:/
1329:e
1322:t
1315:v
1262:.
1240::
1232::
1208:.
1194::
1175:.
1155::
1113:.
1093::
1085::
1026:.
1012::
985:.
973::
932:.
918::
873:.
861::
838:)
824:.
809:.
789::
766:.
739:.
76:)
70:(
65:)
61:(
57:.
47:.
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.